Skip to main content
. 2014 Nov 18;14:94. doi: 10.1186/1471-2482-14-94

Figure 1.

Figure 1

Cancer - specific survival rates according to neutrophil - lymphocyte ratio ( NLR ). The 5-year cancer-specific survival rates were 76.9% and 45.6% in patients with NLR < 3 and NLR ≥ 3, respectively (p = 0.01).